There are currently 2 active clinical trials seeking participants for Pulmonary Fibrosis research studies. The states with the highest number of trials for Pulmonary Fibrosis participants are .
A Non-pharmacological Cough Control Therapy
NCT04767074
Recruiting
Coughing affects almost all individuals with ILD leading to physical, psychological and social distress and prevents individuals from performing their activities of daily living, working or socialising in public places. Unfortunately, there are no licensed medications available to treat chronic cough and the few drugs that have been tried resulted in little efficacy and significant side effects. Drug-free cough control interventions have shown promise in reducing the severity and impact of cough... Read More
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
03/28/2025
Locations: St. Joseph's Healthcare Hamilton, Hamilton, Ontario +1 locations
Conditions: Cough, ILD, Pulmonary Disease, Pulmonary Fibrosis
Register for Updates
Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease
NCT03455686
Recruiting
This is a single centre exploratory study that aims to apply hyperpolarized xenon-129 (129Xe) magnetic resonance imaging (MRI) methods and measurements in individual patients with and without lung disease to better understand lung structure and function and evaluate response to therapy delivered as a part of clinical care.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
05/17/2024
Locations: Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, Ontario
Conditions: Asthma, Chronic Obstructive Pulmonary Disease, Bronchiectasis, Emphysema, Pulmonary Fibrosis, Bronchopulmonary Dysplasia, Alpha 1-Antitrypsin Deficiency, Sarcoidosis, Pulmonary
Register for Updates